ZA953500B - Methods for treating neurofibromatosis - Google Patents

Methods for treating neurofibromatosis

Info

Publication number
ZA953500B
ZA953500B ZA953500A ZA953500A ZA953500B ZA 953500 B ZA953500 B ZA 953500B ZA 953500 A ZA953500 A ZA 953500A ZA 953500 A ZA953500 A ZA 953500A ZA 953500 B ZA953500 B ZA 953500B
Authority
ZA
South Africa
Prior art keywords
methods
cpd
neurofibromatosis
aliphatic
formula
Prior art date
Application number
ZA953500A
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Burnzynski Stanislaw R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burnzynski Stanislaw R filed Critical Burnzynski Stanislaw R
Publication of ZA953500B publication Critical patent/ZA953500B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Activated Sludge Processes (AREA)
ZA953500A 1994-05-04 1995-05-02 Methods for treating neurofibromatosis ZA953500B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/237,772 US5391575A (en) 1994-05-04 1994-05-04 Method for treating neurofibromatosis

Publications (1)

Publication Number Publication Date
ZA953500B true ZA953500B (en) 1996-05-29

Family

ID=22895101

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953500A ZA953500B (en) 1994-05-04 1995-05-02 Methods for treating neurofibromatosis

Country Status (8)

Country Link
US (1) US5391575A (fr)
EP (1) EP0680756B1 (fr)
AT (1) ATE183390T1 (fr)
AU (1) AU683145B2 (fr)
DE (1) DE69511453T2 (fr)
ES (1) ES2139774T3 (fr)
HK (1) HK1016408A1 (fr)
ZA (1) ZA953500B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
US6987131B1 (en) * 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
AU2001285311B2 (en) 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
ES2565848T3 (es) 2004-07-07 2016-04-07 Biocon Limited Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
US20060205818A1 (en) * 2005-03-08 2006-09-14 Burzynski Stanislaw R Method for the treatment of von Hippel-Lindau (VHL) disease with phenylacetyl-derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US5227292A (en) * 1990-07-12 1993-07-13 University Of Utah Neurofibromatosis type 1 gene
US5244922A (en) * 1990-09-04 1993-09-14 Burzynski Stanislaw R Methods for treating viral infections
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis

Also Published As

Publication number Publication date
ATE183390T1 (de) 1999-09-15
US5391575A (en) 1995-02-21
DE69511453T2 (de) 1999-12-09
EP0680756B1 (fr) 1999-08-18
HK1016408A1 (en) 1999-10-29
DE69511453D1 (de) 1999-09-23
EP0680756A1 (fr) 1995-11-08
AU1777595A (en) 1995-11-09
ES2139774T3 (es) 2000-02-16
AU683145B2 (en) 1997-10-30

Similar Documents

Publication Publication Date Title
HUP9800794A2 (hu) (S)-oxi-butinin és (S)-dezetil-oxi-butinin alkalmazása vizelet inkontinencia kezelésére alkalmazható gyógyszerkészítmények előállítására és a vegyületek előállítása
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
HK1004257A1 (en) Use of droloxifene in the treatment of bone diseases
MY106528A (en) Method of treating impotence.
GEP20002300B (en) Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
ZA911496B (en) Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
GR3022519T3 (en) Use of ketoconazole and a retinoid for the treatment of acne vulgaris
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
AU8091787A (en) The use of paroxetine to treat pain
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
ZA953500B (en) Methods for treating neurofibromatosis
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
GR3021813T3 (en) Method of treating alopecia
ZA934021B (en) Treatment of bovine mastitis
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
HUT61199A (en) Process for producing pharmaceutical compositions suitable for treating hyperlipidaemia and/or atherosclerosis
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
GR3022935T3 (en) Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients
Azizbekov et al. Effects of magnetic induction on bacterial wound contamination in children.